Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Maurice J. Gonder is active.

Publication


Featured researches published by Maurice J. Gonder.


Urology | 1984

Sclerotherapy with tetracycline solution for hydrocele

Kang-Ning Hu; Ali Khan; Maurice J. Gonder

A study of sclerotherapy for hydrocele using different concentrations (10%, 5%, 2.5%) for tetracycline solution was done on 24 patients, 23 patients were cured. The effectiveness of sclerotherapy was the same for the three groups of patients with use of each different concentration of the solution. Pain was the only adverse effect. Nonspecific cellular foreign body reaction and fibrin strand proliferation were observed in the hydrocele fluid after this procedure. We consider sclerotherapy for hydrocele with tetracycline solution safe and the procedure of choice for patients in whom surgery or anesthesia is contraindicated, for patients who refuse surgery, and for economic reasons.


The Journal of Urology | 1986

Relationship of Blood Groups and Bladder Cancer

V. Srinivas; S. Ali Khan; S. Hoisington; A. Varma; Maurice J. Gonder

A retrospective study correlating the blood groups of 141 patients with bladder cancer showed that patients with blood group A had lower grade tumors with lower mortality rates, and those with blood group O(H) had higher grade tumors and higher mortality rates.


Diseases of The Colon & Rectum | 1985

Gangrene of male external genitalia in a patient with colorectal disease

S. Ali Khan; Noel L. Smith; Maurice J. Gonder; Biagio Ravo; Padmanabhan Siddharth

This is the report of a patient with gangrene of the skin and subcutaneous tissue of the scrotum and base of the penis secondary to diverticulitis of the sigmoid colon. Due to high mortality in such patients, the prompt recognition of the source of sepsis is of utmost importance. Computed tomography (CT) scanning facilitates delineating the extent of disease. Anatomy of the perineal body and pathways of spread are discussed.


Immunopharmacology | 1988

In vitro effects of diethylstilboestrol and the LHRH analogue leuprolide on natural killer cell activity

Richard J. Ablin; John M. Bartkus; Maurice J. Gonder

In a series of studies of the immunobiological sequelae of oestrogens, the in-vitro effect of diethystilboestrol (DES) and the luteinizing-hormone-releasing-hormone leuprolide (Lupron) on the lytic activity of natural killer (NK) cells have been evaluated. Ficoll-Hypaque gradient-isolated human peripheral blood mononuclear cells (PBMC) were pre-incubated with varying concentrations of DES and leuprolide and the degree of lysis for the human erythroleukemia K-562 cell line was evaluated in a 51Cr-release assay. PBMC pre-incubated with DES exhibited an 82% reduction in the ability of NK cells to lyse K-562 target cells compared with a negligible 3% increase with leuprolide (p less than 0.001) vs. untreated PBMC. The inhibitory effects of DES or leuprolide were not due to cytotoxicity since the viability of PBMC incubated for 18 and 24 h (corresponding to the DES/leuprolide preincubation time and the NK cell assay, respectively) was comparable to that of untreated (control) cells. These observations demonstrate the further suppressive effects of DES on components of immunosurveillance. Pending evaluation of the effect of leuprolide on the activity of NK cells for other target cells, and other parameters of immunologic responsiveness, leuprolide may prove to be a favorable alternative to DES, both in view of its reduced clinical side-effects, and because of the suggested absence of deleterious effects to the immune system. Maintenance of tumour-host equilibrium, and some degree of immunocompetency, in the presence of effective therapy with leuprolide, may prove beneficial in achieving more effective therapy in prostate cancer patients.(ABSTRACT TRUNCATED AT 250 WORDS)


The Journal of Urology | 1985

Bilateral transitional cell carcinoma of the renal pelvis in the cancer family syndrome

Zelig Frischer; Wayne C. Waltzer; Maurice J. Gonder

The cancer family syndrome is an unusual hereditary disease rarely associated with transitional cell carcinoma of the urinary tract. We describe the occurrence of this syndrome in a patient with bilateral transitional cell malignancies.


Urologia Internationalis | 1985

Seminoma in an Atrophic Testis

Ali Khan; V. Srinivas; Maurice J. Gonder

A rare case of a seminoma developing in an atrophic testis is described and the role of testicular atrophy in tumorigenesis is discussed.


International Urology and Nephrology | 1984

Ureteral Replacement with Ileum in Transverse Colon Conduit

Wayne C. Waltzer; Zelik Frischer; Maurice J. Gonder

A case of replacement of a damaged ureter with ileum, in a previously constructed transverse colon conduits, is reported. This is an attractive surgical alternative that deserves a place as a reconstructive procedure in the management of ureteral complications following urinary diversion.


International Urology and Nephrology | 1985

Retroperitoneal haemorrhage with abscess formation complicating Waldenström's macroglobulinaemia

R. Bohus; Wayne C. Waltzer; Zelik Frischer; Maurice J. Gonder

The complications of bleeding in patients with Waldenströms macroglobulinaemia (WM) are relatively well described. The pathophysiology of such a haemorrhagic diathesis is complex and involves the inhibition and depression of coagulation factors as well as qualitative and quantitative platelet abnormalities. Treatment of WM must be targeted at the underlying lymphocellular malignancy, but amelioration of the hyperviscous state and component transfusion(s) to correct abnormal coagulation parameters will decrease the incidence of bleeding. A case of WM withE. coli urinary tract infection and subsequent retroperitoneal haemorrhage with abscess formation and sepsis is presented. The pathophysiology and management of such patients is described.


International Urology and Nephrology | 1985

Squamous cell carcinoma in a horseshoe kidney.

Wayne C. Waltzer; Zelik Frischer; Maurice J. Gonder

The authors describe a case report of a squamous cell carcinoma in a horseshoe kidney and summarize the literature.


The Journal of Urology | 1991

Paradoxical Effects of Cyclosporine on Concanavalin A-Induced Blastogenesis

Moshe Shabtai; Wayne C. Waltzer; Zelik Frischer; John M. Bartkus; Maurice J. Gonder

The effects of increasing in vitro cyclosporine concentrations (0, 50 100 or 200 ng./ml.) on lymphocyte blastogenesis, measured by incorporation of tritiated thymidine and induced by varying levels of concanavalin A (0, 0.25, 1.0 or 5.0 ng./ml.), were studied in regard to mean serum level of cyclosporine in 26 renal allograft recipients. Results were compared to similar data obtained in healthy controls. Patients were divided into group 1 (13 patients, mean serum cyclosporine trough level less than 150 ng./ml.) and group 2 (13 patients, cyclosporine level greater than 150 ng./ml.). With no cyclosporine added to the assay proliferation of lymphocytes obtained from all patients inversely correlated to the mean serum trough cyclosporine level at all stimulatory levels of concanavalin A (0.25 ng./ml., p less than 0.01; 1.0 ng./ml., p less than 0.001 and 5.0 ng./ml., p less than 0.001) and was significantly lower than in controls (p less than 0.0002). Whereas increasing in vitro cyclosporine concentrations has produced the expected increase in suppression of blastogenesis in controls and group 1, a paradoxical effect became evident in group 2. Under stronger stimulatory conditions (concanavalin A 1.0 or 5.0 ng./ml.) increasing in vitro cyclosporine concentrations were associated with significantly decreased suppression of blastogenesis (p less than 0.01) compared to group 1. These results confirm previous reports and suggest that the duality of effect of cyclosporine in this in vitro model may be related to its functional relationship to the calcium ion (Ca++)/calmodulin complex and to its cellular concentration/solubility curve. These considerations may be of importance in adjusting cyclosporine dosage based on serum trough levels of cyclosporine.

Collaboration


Dive into the Maurice J. Gonder's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Ali Khan

Stony Brook University

View shared research outputs
Top Co-Authors

Avatar

Biagio Ravo

Stony Brook University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

S. Ali Khan

Stony Brook University

View shared research outputs
Top Co-Authors

Avatar

V. Srinivas

Stony Brook University

View shared research outputs
Researchain Logo
Decentralizing Knowledge